Medicamentos de Administracion Oral
SUMINISTRO DE MEDICAMENTOS DE ADMINISTRACION ORAL PARA EL HOSPITAL DR. EXEQUIEL GONZÁLEZ CORTÉS
17 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 1058090-1493-SE21 | 26-10-2021 | Laboratorios Saval S.A. | $942.480 |
| 1058090-1476-SE21 | 21-10-2021 | Laboratorios Andromaco S.A. | $236.808 |
| 1058090-1367-SE21 | 14-09-2021 | Laboratorios Saval S.A. | $471.240 |
| 1058090-1211-SE21 | 20-08-2021 | Synthon Chile Limitada | $2.796.500 |
| 1058090-1152-SE21 | 09-08-2021 | Laboratorios Saval S.A. | $942.480 |
| 1058090-1143-SE21 | 06-08-2021 | Laboratorios Andromaco S.A. | $37.128 |
| 1058090-1082-SE21 | 28-07-2021 | Pfizer Chile S.A. | $9.315.796 |
| 1058090-1073-SE21 | 27-07-2021 | Industrial y Comercial Baxter de Chile Limitada | $13.090 |
| 1058090-1074-SE21 | 27-07-2021 | Industrial y Comercial Baxter de Chile Limitada | $654.500 |
| 1058090-1036-SE21 | 22-07-2021 | Synthon Chile Limitada | $2.796.500 |
| 1058090-986-SE21 | 13-07-2021 | Synthon Chile Limitada | $2.796.500 |
| 1058090-969-SE21 | 13-07-2021 | Laboratorios Saval S.A. | $471.240 |
| 1058090-955-SE21 | 08-07-2021 | Laboratorios Andromaco S.A. | $37.128 |
| 1058090-802-SE21 | 07-06-2021 | Laboratorios Andromaco S.A. | $52.360 |
| 1058090-745-SE21 | 28-05-2021 | Laboratorios Saval S.A. | $706.860 |
| 1058090-725-SE21 | 26-05-2021 | Industrial y Comercial Baxter de Chile Limitada | $1.309.000 |
| 1058090-707-SE21 | 17-05-2021 | Pfizer Chile S.A. | $1.745.016 |
| 1058090-706-SE21 | 17-05-2021 | Synthon Chile Limitada | $2.796.500 |
| 1058090-658-SE21 | 10-05-2021 | Laboratorios Saval S.A. | $471.240 |
| 1058090-650-SE21 | 07-05-2021 | Pfizer Chile S.A. | $4.657.898 |
| 1058090-581-SE21 | 28-04-2021 | Industrial y Comercial Baxter de Chile Limitada | $654.500 |
| 1058090-563-SE21 | 22-04-2021 | Pfizer Chile S.A. | $4.657.898 |
| 1058090-509-SE21 | 09-04-2021 | Laboratorios Saval S.A. | $471.240 |
| 1058090-471-SE21 | 07-04-2021 | Pfizer Chile S.A. | $6.986.847 |
| 1058090-449-SE21 | 30-03-2021 | Pfizer Chile S.A. | $4.657.898 |
| 1058090-417-SE21 | 23-03-2021 | Laboratorios Saval S.A. | $471.240 |
| 1058090-367-SE21 | 11-03-2021 | Pfizer Chile S.A. | $4.657.898 |
| 1058090-321-SE21 | 04-03-2021 | Pfizer Chile S.A. | $2.328.949 |
| 1058090-254-SE21 | 18-02-2021 | Pfizer Chile S.A. | $5.239.570 |
| 1058090-204-SE21 | 08-02-2021 | Laboratorios Saval S.A. | $471.240 |
| 1058090-39-SE21 | 07-01-2021 | Laboratorios Saval S.A. | $471.240 |
| 1058090-1619-SE20 | 10-12-2020 | Laboratorios Saval S.A. | $471.240 |
| 1058090-1527-SE20 | 06-11-2020 | Winpharm SpA | $67.830 |
| 1058090-1504-SE20 | 05-11-2020 | Laboratorios Saval S.A. | $706.860 |
| 1058090-1494-SE20 | 04-11-2020 | Laboratorios Andromaco S.A. | $74.256 |
| 1058090-1441-SE20 | 28-10-2020 | Laboratorios Andromaco S.A. | $185.640 |
| 1058090-1393-SE20 | 07-10-2020 | Laboratorios Saval S.A. | $235.620 |
| 1058090-1388-SE20 | 07-10-2020 | Laboratorios Andromaco S.A. | $22.277 |
| 1058090-1209-SE20 | 25-08-2020 | Laboratorios Andromaco S.A. | $55.692 |
| 1058090-1095-SE20 | 28-07-2020 | Laboratorios Saval S.A. | $471.240 |
| 1058090-1084-SE20 | 24-07-2020 | Laboratorios Saval S.A. | $471.240 |
| 1058090-978-SE20 | 24-06-2020 | Pfizer Chile S.A. | $698.685 |
| 1058090-958-SE20 | 12-06-2020 | Pfizer Chile S.A. | $698.685 |
| 1058090-704-SE20 | 16-04-2020 | Synthon Chile Limitada | $5.593.000 |
| 1058090-643-SE20 | 08-04-2020 | Laboratorios Saval S.A. | $1.178.100 |
| 1058090-613-SE20 | 06-04-2020 | Novartis Chile S.A. | $6.064.440 |
| 1058090-593-SE20 | 02-04-2020 | Synthon Chile Limitada | $1.677.900 |
| 1058090-565-SE20 | 31-03-2020 | Laboratorios Andromaco S.A. | $92.224 |
| 1058090-416-SE20 | 12-03-2020 | Laboratorios Saval S.A. | $141.372 |
| 1058090-397-SE20 | 11-03-2020 | Laboratorios Andromaco S.A. | $36.842 |
| 1058090-352-SE20 | 06-03-2020 | Pfizer Chile S.A. | $2.794.739 |
| 1058090-282-SE20 | 12-02-2020 | Laboratorios Saval S.A. | $706.860 |
| 1058090-239-SE20 | 07-02-2020 | Laboratorios Andromaco S.A. | $37.128 |
| 1058090-96-SE20 | 08-01-2020 | Synthon Chile Limitada | $1.118.600 |
| 1058090-37-SE20 | 06-01-2020 | Laboratorios Andromaco S.A. | $37.128 |
| 1058090-1848-SE19 | 31-12-2019 | Synthon Chile Limitada | $1.957.550 |
| 1058090-1758-SE19 | 13-12-2019 | Novartis Chile S.A. | $3.307.876 |
| 1058090-1787-SE19 | 12-12-2019 | Pfizer Chile S.A. | $116.334 |
| 1058090-1796-SE19 | 12-12-2019 | Laboratorios Saval S.A. | $188.496 |
| 1058090-1679-SE19 | 29-11-2019 | Pfizer Chile S.A. | $174.502 |
| 1058090-1611-SE19 | 19-11-2019 | Laboratorios Saval S.A. | $706.860 |
| 1058090-1588-SE19 | 14-11-2019 | Novartis Chile S.A. | $826.969 |
| 1058090-1540-SE19 | 12-11-2019 | Laboratorios Andromaco S.A. | $37.128 |
| 1058090-1422-SE19 | 14-10-2019 | Novartis Chile S.A. | $826.969 |
Fuente original:ficha mercadopublico.cl
